|
EP2435414B1
(en)
|
2009-05-27 |
2015-08-19 |
Atir Holding S.A. |
Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
|
|
KR101178181B1
(ko)
*
|
2010-09-17 |
2012-09-19 |
대한민국(농촌진흥청장) |
신규한 항생활성 화합물 및 그 화합물을 포함하는 항생 조성물
|
|
WO2012049555A1
(en)
|
2010-10-13 |
2012-04-19 |
Lupin Limited |
Spirocyclic compounds as voltage-gated sodium channel modulators
|
|
JP2014518281A
(ja)
*
|
2011-07-06 |
2014-07-28 |
グラクソ グループ リミテッド |
電位依存性ナトリウムチャネル遮断薬
|
|
CN104093716B
(zh)
*
|
2011-10-31 |
2017-06-23 |
克赛农制药股份有限公司 |
联芳醚磺酰胺化合物及其作为治疗剂的用途
|
|
CN104024251B
(zh)
*
|
2011-10-31 |
2017-08-11 |
克赛农制药股份有限公司 |
苯磺酰胺化合物及其作为治疗剂的用途
|
|
AP2014007805A0
(en)
|
2011-12-28 |
2014-07-31 |
Cytokinetics Inc The Regents Of The University Of California |
Substituted benzaldehyde compounds and methods fortheir use in increasing tissue oxygenation
|
|
WO2013102145A1
(en)
|
2011-12-28 |
2013-07-04 |
Global Blood Therapeutics, Inc. |
Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
AR091112A1
(es)
|
2012-05-22 |
2015-01-14 |
Genentech Inc |
Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7
|
|
BR112015000187A2
(pt)
|
2012-07-06 |
2017-06-27 |
Genentech Inc |
benzamidas substituídas com n e métodos de uso das mesmas
|
|
ES2750640T3
(es)
*
|
2012-08-16 |
2020-03-26 |
Scripps Research Inst |
Ligandos opioides kappa novedosos
|
|
CN105263490B
(zh)
|
2013-03-14 |
2018-05-22 |
基因泰克公司 |
取代的三唑并吡啶及其使用方法
|
|
US9597330B2
(en)
|
2013-03-14 |
2017-03-21 |
Daiichi Sankyo Company, Limited |
Drugs for treating respiratory diseases
|
|
ES2852054T3
(es)
|
2013-03-15 |
2021-09-10 |
Global Blood Therapeutics Inc |
Compuestos y usos de los mismos para la modulación de hemoglobina
|
|
US10100043B2
(en)
|
2013-03-15 |
2018-10-16 |
Global Blood Therapeutics, Inc. |
Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
|
|
US10266551B2
(en)
|
2013-03-15 |
2019-04-23 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
MX2015010775A
(es)
|
2013-03-15 |
2016-04-25 |
Genentech Inc |
Benzoxazoles sustituidos y metodos para usarlos.
|
|
MY180206A
(en)
|
2013-03-15 |
2020-11-25 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
CN105209469A
(zh)
*
|
2013-03-15 |
2015-12-30 |
全球血液疗法股份有限公司 |
化合物及其用于调节血红蛋白的用途
|
|
AP2015008718A0
(en)
|
2013-03-15 |
2015-09-30 |
Global Blood Therapeutics Inc |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US9458139B2
(en)
|
2013-03-15 |
2016-10-04 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
US8952171B2
(en)
|
2013-03-15 |
2015-02-10 |
Global Blood Therapeutics, Inc. |
Compounds and uses thereof for the modulation of hemoglobin
|
|
WO2014165816A1
(en)
|
2013-04-05 |
2014-10-09 |
North Carolina Central University |
Compounds useful for the treatment of metabolic disorders and synthesis of the same
|
|
EA202092627A1
(ru)
|
2013-11-18 |
2021-09-30 |
Глобал Блад Терапьютикс, Инк. |
Соединения и их применения для модуляции гемоглобина
|
|
EA201691085A1
(ru)
|
2013-11-27 |
2017-02-28 |
Дженентек, Инк. |
Замещенные бензамиды и способы их применения
|
|
US9975876B2
(en)
|
2013-12-09 |
2018-05-22 |
Merck Sharp & Dohme Corp. |
2-pyridyloxy-3-ester-4-ether orexin receptor antagonists
|
|
JP6045487B2
(ja)
*
|
2013-12-25 |
2016-12-14 |
シャープ株式会社 |
操作入力システム、電子機器、携帯端末、及び操作入力方法
|
|
SG10201911668VA
(en)
|
2014-02-07 |
2020-01-30 |
Global Blood Therapeutics Inc |
Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
|
|
AU2015223049B2
(en)
*
|
2014-02-27 |
2019-03-21 |
Merck Patent Gmbh |
Heterocyclic compounds as NaV channel inhibitors and uses thereof
|
|
EP3126360A1
(en)
|
2014-03-29 |
2017-02-08 |
Lupin Limited |
Sulfonamide compounds as voltage gated sodium channel modulators
|
|
WO2016007534A1
(en)
|
2014-07-07 |
2016-01-14 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
WO2016021742A1
(en)
|
2014-08-07 |
2016-02-11 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds as ep4 receptor antagonists
|
|
JP2018520107A
(ja)
|
2015-05-22 |
2018-07-26 |
ジェネンテック， インコーポレイテッド |
置換ベンズアミド及びその使用方法
|
|
JP2018526371A
(ja)
|
2015-08-27 |
2018-09-13 |
ジェネンテック， インコーポレイテッド |
治療化合物及びその使用方法
|
|
TW201722938A
(zh)
|
2015-09-04 |
2017-07-01 |
魯賓有限公司 |
作為電位閘控鈉通道調節子之磺醯胺化合物
|
|
SG10202007787RA
(en)
|
2015-09-28 |
2020-09-29 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
|
US10899732B2
(en)
|
2015-11-25 |
2021-01-26 |
Genentech, Inc. |
Substituted benzamides useful as sodium channel blockers
|
|
HUE072191T2
(hu)
|
2015-12-04 |
2025-10-28 |
Global Blood Therapeutics Inc |
A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje
|
|
AU2017215697A1
(en)
|
2016-02-03 |
2018-07-05 |
Shanghai Haiyan Pharmaceutical Technology Co., Ltd. |
N-sulfonyl benzamide derivative with heterocyclic substituent, preparation method therefor and pharmaceutical application thereof
|
|
EP3436432B1
(en)
|
2016-03-30 |
2021-01-27 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
TWI663160B
(zh)
|
2016-05-12 |
2019-06-21 |
全球血液治療公司 |
用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
|
|
TW202332423A
(zh)
|
2016-10-12 |
2023-08-16 |
美商全球血液治療公司 |
包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
|
|
CN110072855A
(zh)
|
2016-10-17 |
2019-07-30 |
基因泰克公司 |
治疗性化合物及其使用方法
|
|
WO2018163077A1
(en)
|
2017-03-08 |
2018-09-13 |
Lupin Limited |
Indanyl compounds as voltage gated sodium channel modulators
|
|
EP3601273B1
(en)
|
2017-03-24 |
2021-12-01 |
Genentech, Inc. |
4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
|
|
US11028075B2
(en)
|
2018-02-26 |
2021-06-08 |
Genentech, Inc. |
Therapeutic compounds and methods of use thereof
|
|
CN111936494A
(zh)
|
2018-03-30 |
2020-11-13 |
豪夫迈·罗氏有限公司 |
作为钠通道抑制剂的取代的氢-吡啶并-吖嗪
|
|
TW202003490A
(zh)
|
2018-05-22 |
2020-01-16 |
瑞士商赫孚孟拉羅股份公司 |
治療性化合物及其使用方法
|
|
ES2966707T3
(es)
|
2018-10-01 |
2024-04-23 |
Global Blood Therapeutics Inc |
Moduladores de la hemoglobina para el tratamiento de la drepanocitosis
|
|
CN109796402A
(zh)
*
|
2018-12-28 |
2019-05-24 |
京博农化科技有限公司 |
一种烟嘧磺隆中间体2-氯-n，n-二甲基烟酰胺的制备方法
|
|
KR102845511B1
(ko)
|
2019-02-08 |
2025-08-12 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
|
JP7413346B2
(ja)
|
2019-03-06 |
2024-01-15 |
第一三共株式会社 |
ピロロピラゾール誘導体
|